{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:50:23Z","timestamp":1791420623675,"version":"4.3.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer stem cells (CSCs) can adapt their metabolism, which limits the effectiveness of therapies targeting metabolic pathways. Here we show that high glucose conditions promote metformin resistance in CD133\u207a colorectal CSCs by driving a switch from glucose dependence to lipid use. Mechanistically, metformin increases LDHA-dependent lactate production in these cells under high glucose conditions. Lactate accumulation enhances histone H3 lysine 18 lactylation (H3K18la), which activates c-JUN and induces CD36 expression. CD36 promotes free fatty acid (FFA) uptake and lipid droplet (LD) formation, providing fuel for fatty acid \u03b2-oxidation. This process generates ATP and NADPH, reduces energy stress and reactive oxygen species, and thereby supports CSC survival during metformin treatment. In vitro and in vivo, inhibition of either LDHA or CD36 restores metformin sensitivity in CD133\u207a colorectal CSCs. These findings identify a lactate-driven epigenetic and metabolic pathway underlying metformin resistance and suggest LDHA and CD36 as potential therapeutic targets.<\/jats:p>","DOI":"10.1038\/s41467-026-77051-9","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:03:50Z","timestamp":1788807830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose-induced histone lactylation confers metformin resistance in colorectal cancer stem cells"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiang-Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-De","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Han","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Qi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ting","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-5129","authenticated-orcid":false,"given":"Zhi-Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-8693","authenticated-orcid":false,"given":"Han-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"77051_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med 346, 393\u2013403 (2002).","journal-title":"N. Engl. J. Med"},{"key":"77051_CR2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton, W. W. et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife 3, e02242 (2014).","journal-title":"Elife"},{"key":"77051_CR3","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1016\/j.celrep.2019.11.007","volume":"29","author":"H Khan","year":"2019","unstructured":"Khan, H. et al. Metabolic rewiring in response to biguanides is mediated by mROS\/HIF-1a in malignant lymphocytes. Cell Rep. 29, 3009\u20133018 e3004 (2019).","journal-title":"Cell Rep."},{"key":"77051_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18762-4","volume":"8","author":"JH Kim","year":"2018","unstructured":"Kim, J. H. et al. Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism. Sci. Rep. 8, 409 (2018).","journal-title":"Sci. Rep."},{"key":"77051_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","volume":"24","author":"X Liu","year":"2016","unstructured":"Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E. & Locasale, J. W. Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers. Cell Metab. 24, 728\u2013739 (2016).","journal-title":"Cell Metab."},{"key":"77051_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","volume":"33","author":"AS Krall","year":"2021","unstructured":"Krall, A. S. et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 33, 1013\u20131026 e1016 (2021).","journal-title":"Cell Metab."},{"key":"77051_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s42255-021-00393-9","volume":"3","author":"JA Wali","year":"2021","unstructured":"Wali, J. A. et al. Impact of dietary carbohydrate type and protein-carbohydrate interaction on metabolic health. Nat. Metab. 3, 810\u2013828 (2021).","journal-title":"Nat. Metab."},{"key":"77051_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S2213-8587(24)00069-X","volume":"12","author":"V Miller","year":"2024","unstructured":"Miller, V. et al. Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study. Lancet Diab. Endocrinol. 12, 330\u2013338 (2024).","journal-title":"Lancet Diab. Endocrinol."},{"key":"77051_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.stem.2014.11.012","volume":"15","author":"A Zeuner","year":"2014","unstructured":"Zeuner, A., Todaro, M., Stassi, G. & De Maria, R. Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell 15, 692\u2013705 (2014).","journal-title":"Cell Stem Cell"},{"key":"77051_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","volume":"74","author":"C Raggi","year":"2021","unstructured":"Raggi, C. et al. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. J. Hepatol. 74, 1373\u20131385 (2021).","journal-title":"J. Hepatol."},{"key":"77051_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","volume":"22","author":"P Sancho","year":"2015","unstructured":"Sancho, P. et al. MYC\/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells. Cell Metab. 22, 590\u2013605 (2015).","journal-title":"Cell Metab."},{"key":"77051_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/ijc.25944","volume":"129","author":"XQ Ye","year":"2011","unstructured":"Ye, X. Q. et al. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int. J. Cancer 129, 820\u2013831 (2011).","journal-title":"Int. J. Cancer"},{"key":"77051_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329\u2013341 (2013).","journal-title":"Cell Stem Cell"},{"key":"77051_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1470-2045(15)00027-3","volume":"16","author":"S Kordes","year":"2015","unstructured":"Kordes, S. et al. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. 16, 839\u2013847 (2015).","journal-title":"Lancet Oncol."},{"key":"77051_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/carcin\/bgy174","volume":"40","author":"A Banerjee","year":"2019","unstructured":"Banerjee, A. et al. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization. Carcinogenesis 40, 871\u2013882 (2019).","journal-title":"Carcinogenesis"},{"key":"77051_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","journal-title":"Nature"},{"key":"77051_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187, 294\u2013311 e221 (2024).","journal-title":"Cell"},{"key":"77051_CR18","doi-asserted-by":"publisher","first-page":"113112","DOI":"10.1016\/j.yexcr.2022.113112","volume":"415","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia. Exp. Cell Res 415, 113112 (2022).","journal-title":"Exp. Cell Res"},{"key":"77051_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye, H. et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell 19, 23\u201337 (2016).","journal-title":"Cell Stem Cell"},{"key":"77051_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41\u201345 (2017).","journal-title":"Nature"},{"key":"77051_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","volume":"35","author":"M Elgendy","year":"2019","unstructured":"Elgendy, M. et al. Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3beta-MCL-1 axis. Cancer Cell 35, 798\u2013815 e795 (2019).","journal-title":"Cancer Cell"},{"key":"77051_CR22","doi-asserted-by":"publisher","first-page":"20794","DOI":"10.1074\/jbc.C700070200","volume":"282","author":"JH Um","year":"2007","unstructured":"Um, J. H. et al. Activation of 5\u2019-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. J. Biol. Chem. 282, 20794\u201320798 (2007).","journal-title":"J. Biol. Chem."},{"key":"77051_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","volume":"24","author":"N Sachs","year":"2014","unstructured":"Sachs, N. & Clevers, H. Organoid cultures for the analysis of cancer phenotypes. Curr. Opin. Genet Dev. 24, 68\u201373 (2014).","journal-title":"Curr. Opin. Genet Dev."},{"key":"77051_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature13110","volume":"508","author":"K Birsoy","year":"2014","unstructured":"Birsoy, K. et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508, 108\u2013112 (2014).","journal-title":"Nature"},{"key":"77051_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13046-019-1405-7","volume":"38","author":"SY Park","year":"2019","unstructured":"Park, S. Y. et al. The JAK2\/STAT3\/CCND2 axis promotes colorectal Cancer stem cell persistence and radioresistance. J. Exp. Clin. Cancer Res 38, 399 (2019).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"77051_CR26","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/stem.1716","volume":"32","author":"JS Hale","year":"2014","unstructured":"Hale, J. S. et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells 32, 1746\u20131758 (2014).","journal-title":"Stem Cells"},{"key":"77051_CR27","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","volume":"29","author":"WW Feng","year":"2019","unstructured":"Feng, W. W. et al. CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies. Cell Rep. 29, 3405\u20133420 e3405 (2019).","journal-title":"Cell Rep."},{"key":"77051_CR28","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi, A. et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37, 2285\u20132301 (2018).","journal-title":"Oncogene"},{"key":"77051_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge, E. et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 33, 1701\u20131715 e1705 (2021).","journal-title":"Cell Metab."},{"key":"77051_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160, 177\u2013190 (2015).","journal-title":"Cell"},{"key":"77051_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","volume":"9","author":"K Bensaad","year":"2014","unstructured":"Bensaad, K. et al. Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation. Cell Rep. 9, 349\u2013365 (2014).","journal-title":"Cell Rep."},{"key":"77051_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon, S. M., Chandel, N. S. & Hay, N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485, 661\u2013665 (2012).","journal-title":"Nature"},{"key":"77051_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo, A., Cantley, L. C. & Pandolfi, P. P. Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 13, 227\u2013232 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"77051_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.2337\/db13-0194","volume":"63","author":"JJ Geerling","year":"2014","unstructured":"Geerling, J. J. et al. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 63, 880\u2013891 (2014).","journal-title":"Diabetes"},{"key":"77051_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest 108, 1167\u20131174 (2001).","journal-title":"J. Clin. Invest"},{"key":"77051_CR36","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542\u2013546 (2014).","journal-title":"Nature"},{"key":"77051_CR37","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","volume":"70","author":"I Ben Sahra","year":"2010","unstructured":"Ben Sahra, I. et al. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res 70, 2465\u20132475 (2010).","journal-title":"Cancer Res"},{"key":"77051_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0555-x","volume":"15","author":"A Deshmukh","year":"2016","unstructured":"Deshmukh, A., Deshpande, K., Arfuso, F., Newsholme, P. & Dharmarajan, A. Cancer stem cell metabolism: a potential target for cancer therapy. Mol. Cancer 15, 69 (2016).","journal-title":"Mol. Cancer"},{"key":"77051_CR39","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-15-2038","volume":"76","author":"M Bacci","year":"2016","unstructured":"Bacci, M. et al. miR-155 drives metabolic reprogramming of ER+ breast cancer cells following long-term estrogen deprivation and predicts clinical response to aromatase inhibitors. Cancer Res 76, 1615\u20131626 (2016).","journal-title":"Cancer Res"},{"key":"77051_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1158\/0008-5472.CAN-13-2037","volume":"75","author":"M Curtarello","year":"2015","unstructured":"Curtarello, M. et al. VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells. Cancer Res 75, 120\u2013133 (2015).","journal-title":"Cancer Res"},{"key":"77051_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","volume":"28","author":"M Apicella","year":"2018","unstructured":"Apicella, M. et al. Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies. Cell Metab. 28, 848\u2013865 e846 (2018).","journal-title":"Cell Metab."},{"key":"77051_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"77051_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito, L., Morandi, A., Giannoni, E. & Chiarugi, P. Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci. 44, 153\u2013166 (2019).","journal-title":"Trends Biochem Sci."},{"key":"77051_CR44","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1038\/onc.2017.188","volume":"36","author":"J Feng","year":"2017","unstructured":"Feng, J. et al. Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Oncogene 36, 5829\u20135839 (2017).","journal-title":"Oncogene"},{"key":"77051_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13046-018-0701-y","volume":"37","author":"X Li","year":"2018","unstructured":"Li, X. et al. Upregulation of lactate-inducible snail protein suppresses oncogene-mediated senescence through p16(INK4a) inactivation. J. Exp. Clin. Cancer Res. 37, 39 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"77051_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-020-01686-9","volume":"39","author":"A Brennan","year":"2020","unstructured":"Brennan, A., Leech, J. T., Kad, N. M. & Mason, J. M. Selective antagonism of cJun for cancer therapy. J. Exp. Clin. Cancer Res. 39, 184 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"77051_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"77051_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","volume":"37","author":"R Zhu","year":"2025","unstructured":"Zhu, R. et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 37, 361\u2013376 e367 (2025).","journal-title":"Cell Metab."},{"key":"77051_CR49","doi-asserted-by":"publisher","first-page":"700795","DOI":"10.3389\/fonc.2021.700795","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Expression and clinical significance of lactate dehydrogenase A in colon adenocarcinoma. Front Oncol. 11, 700795 (2021).","journal-title":"Front Oncol."},{"key":"77051_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2276-3","volume":"16","author":"G Li","year":"2016","unstructured":"Li, G. et al. The prognostic value of lactate dehydrogenase levels in colorectal cancer: a meta-analysis. BMC Cancer 16, 249 (2016).","journal-title":"BMC Cancer"},{"key":"77051_CR51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/bjc.2016.413","volume":"116","author":"F Marmorino","year":"2017","unstructured":"Marmorino, F. et al. Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer. Br. J. Cancer 116, 318\u2013323 (2017).","journal-title":"Br. J. Cancer"},{"key":"77051_CR52","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1158\/1078-0432.CCR-10-2918","volume":"17","author":"MI Koukourakis","year":"2011","unstructured":"Koukourakis, M. I. et al. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787\/ZK 222584 (vatalanib) antiangiogenic therapy. Clin. Cancer Res. 17, 4892\u20134900 (2011).","journal-title":"Clin. Cancer Res."},{"key":"77051_CR53","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.7150\/thno.73746","volume":"12","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. N(6)-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming. Theranostics 12, 4802\u20134817 (2022).","journal-title":"Theranostics"},{"key":"77051_CR54","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.omtn.2020.12.020","volume":"23","author":"XL Zhang","year":"2021","unstructured":"Zhang, X. L., Li, K. J., Feng, J. X., Liu, G. J. & Feng, Y. L. Blocking the IGF2BP1-promoted glucose metabolism of colon cancer cells via direct de-stabilizing mRNA of the LDHA enhances anticancer effects. Mol. Ther. Nucleic Acids 23, 835\u2013846 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"77051_CR55","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/j.molcel.2025.06.019","volume":"85","author":"M Jin","year":"2025","unstructured":"Jin, M. et al. Lactylation of XLF promotes non-homologous end-joining repair and chemoresistance in cancer. Mol. Cell 85, 2654\u20132672 e2657 (2025).","journal-title":"Mol. Cell"},{"key":"77051_CR56","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller, L. H. & Schrag, D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325, 669\u2013685 (2021).","journal-title":"JAMA"},{"key":"77051_CR57","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med 17, 1086\u20131093 (2011).","journal-title":"Nat. Med"},{"key":"77051_CR58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban, R. S., Nemoto, S. & Finkel, T. Mitochondria, oxidants, and aging. Cell 120, 483\u2013495 (2005).","journal-title":"Cell"},{"key":"77051_CR59","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cmet.2018.08.021","volume":"28","author":"SR Lord","year":"2018","unstructured":"Lord, S. R. et al. Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer. Cell Metab. 28, 679\u2013688 e674 (2018).","journal-title":"Cell Metab."},{"key":"77051_CR60","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell Rep. 29, 1511\u20131523 e1515 (2019).","journal-title":"Cell Rep."},{"key":"77051_CR61","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/bjc.2016.152","volume":"114","author":"P Sancho","year":"2016","unstructured":"Sancho, P., Barneda, D. & Heeschen, C. Hallmarks of cancer stem cell metabolism. Br. J. Cancer 114, 1305\u20131312 (2016).","journal-title":"Br. J. Cancer"},{"key":"77051_CR62","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.1158\/1078-0432.CCR-19-0437","volume":"25","author":"L Li","year":"2019","unstructured":"Li, L. et al. Combination of metformin and gefitinib as first-line therapy for nondiabetic advanced NSCLC patients with EGFR mutations: a randomized, double-blind phase II trial. Clin. Cancer Res 25, 6967\u20136975 (2019).","journal-title":"Clin. Cancer Res"},{"key":"77051_CR63","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaoncol.2021.2328","volume":"7","author":"T Tsakiridis","year":"2021","unstructured":"Tsakiridis, T. et al. Metformin in combination with chemoradiotherapy in locally advanced non-small cell lung cancer: the OCOG-ALMERA randomized clinical trial. JAMA Oncol. 7, 1333\u20131341 (2021).","journal-title":"JAMA Oncol."},{"key":"77051_CR64","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540\u2013551 (2015).","journal-title":"Cell"},{"key":"77051_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3236","volume":"4","author":"SM Fendt","year":"2013","unstructured":"Fendt, S. M. et al. Reductive glutamine metabolism is a function of the alpha-ketoglutarate to citrate ratio in cells. Nat. Commun. 4, 2236 (2013).","journal-title":"Nat. Commun."},{"key":"77051_CR66","doi-asserted-by":"publisher","first-page":"10574","DOI":"10.1073\/pnas.1409844111","volume":"111","author":"A Janzer","year":"2014","unstructured":"Janzer, A. et al. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proc. Natl. Acad. Sci. USA 111, 10574\u201310579 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77051_CR67","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann, J. A. & Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 20, 137\u2013155 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"77051_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14262-3","volume":"11","author":"C Corbet","year":"2020","unstructured":"Corbet, C. et al. TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells. Nat. Commun. 11, 454 (2020).","journal-title":"Nat. Commun."},{"key":"77051_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00324-7","volume":"7","author":"J Gyamfi","year":"2021","unstructured":"Gyamfi, J. et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer 7, 129 (2021).","journal-title":"NPJ Breast Cancer"},{"key":"77051_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jcmm.13927","volume":"23","author":"F Erhart","year":"2019","unstructured":"Erhart, F. et al. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+\/CD133+\/ITGA6+\/CD36+ signature. J. Cell Mol. Med 23, 281\u2013292 (2019).","journal-title":"J. Cell Mol. Med"},{"key":"77051_CR71","volume":"11","author":"Q Yue","year":"2024","unstructured":"Yue, Q. et al. Histone H3K9 lactylation confers temozolomide resistance in glioblastoma via LUC7L2-mediated MLH1 intron retention. Adv. Sci. (Weinh.) 11, e2309290 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"77051_CR72","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R DeFronzo","year":"2016","unstructured":"DeFronzo, R., Fleming, G. A., Chen, K. & Bicsak, T. A. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism 65, 20\u201329 (2016).","journal-title":"Metabolism"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77051-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:03:00Z","timestamp":1791417780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77051-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77051"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77051-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10594"}}